IV LEAKS Trademark

Trademark Overview

On Monday, April 3, 2023, a trademark application was filed for IV LEAKS with the United States Patent and Trademark Office. The USPTO has given the IV LEAKS trademark a serial number of 97869677. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, January 27, 2025. This trademark is owned by IV LEAKS LLC. The IV LEAKS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a website featuring temporary use of non-downloadable software for providing a treatment resource to healthcare professional for database management, reporting, and education of drug infiltrations and extravasations
iv leaks

General Information

Serial Number97869677
Word MarkIV LEAKS
Filing DateMonday, April 3, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, January 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding a website featuring temporary use of non-downloadable software for providing a treatment resource to healthcare professional for database management, reporting, and education of drug infiltrations and extravasations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 26, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIV LEAKS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFlemington, NJ 08822

Trademark Events

Event DateEvent Description
Thursday, April 6, 2023NEW APPLICATION ENTERED
Wednesday, April 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 29, 2023ASSIGNED TO EXAMINER
Friday, January 19, 2024NON-FINAL ACTION WRITTEN
Friday, January 19, 2024NON-FINAL ACTION E-MAILED
Friday, January 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, April 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 25, 2024NON-FINAL ACTION E-MAILED
Thursday, July 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 25, 2024NON-FINAL ACTION WRITTEN
Friday, October 25, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 25, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sunday, January 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 27, 2025FINAL REFUSAL E-MAILED
Monday, January 27, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 27, 2025FINAL REFUSAL WRITTEN

Related Keywords

leaks providing management database reporting education extravasations infiltrations drug professional healthcare